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Abstract
Prior studies suggest that the hydrophobic surfactant proteins, SP-B and SP-C, promote adsorption
of the lipids in pulmonary surfactant to an air–water interface by stabilizing a negatively curved
rate-limiting structure that is intermediate between bilayer vesicles and the surface film. This
model predicts that other peptides capable of stabilizing negative curvature should also promote
lipid adsorption. Previous reports have shown that under appropriate conditions, gramicidin-A
(GrA) induces dioleoyl phosphatidylcholine (DOPC), but not dimyristoyl phosphatidylcholine
(DMPC), to form the negatively curved hexagonal-II (HII) phase. The studies reported here
determined if GrA would produce the same effects on adsorption of DMPC and DOPC that the
hydrophobic surfactant proteins have on the surfactant lipids. Small angle X-ray scattering
and 31P-nuclear magnetic resonance confirmed that at the particular conditions used to study
adsorption, GrA induced DOPC to form the HII phase, but DMPC remained lamellar.
Measurements of surface tension showed that GrA in vesicles produced a general increase in the
rate of adsorption for both phospholipids. When restricted to the interface, however, in preexisting
films, GrA with DOPC, but not with DMPC, replicated the ability of the surfactant proteins to
promote adsorption of vesicles containing only the lipids. The correlation between the structural
and functional effects of GrA with the two phospholipids, and the similar effects on adsorption of
GrA with DOPC and the hydrophobic surfactant proteins with the surfactant lipids fit with the
model in which SP-B and SP-C facilitate adsorption by stabilizing a rate-limiting intermediate
with negative curvature.
Keywords
Gramicidin; Lipid polymorphism; 31P nuclear magnetic resonance; Pulmonary surfactant;
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1. Introduction
Pulmonary surfactant is the mix of lipids and proteins secreted by the type II pneumocytes
that forms a thin film at the air–water interface of the alveolar air spaces. When compressed
by the shrinking interfacial area during exhalation, the films reduce surface tension to
remarkably low levels [1–5]. This function is essential for normal respiration. In premature
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babies who lack adequate amounts of surfactant, the increased surface tension collapses the
alveoli, which then become injured during subsequent ventilation, leading to the flooded air
spaces and respiratory failure of the Respiratory Distress Syndrome (RDS) [6].
Available evidence suggests that the surfactant films form rapidly. Immediately following
birth when newborn babies first create the air–water interface, pulmonary mechanics are
normal within the first few breaths [7]. In lungs made stiff by inactivation of surfactant
during prolonged ventilation at a constant tidal volume, a single deep inspiration restores
normal mechanics during the first exhalation [8]. Surfactant vesicles must therefore adsorb
to create the interfacial film within seconds. The importance of the hydrophobic surfactant
proteins, SP-B and SP-C, suggests that this rapid adsorption is essential. SP-B and SP-C
greatly accelerate the adsorption of the surfactant lipids in vitro [9]. The congenital absence
of SP-B, caused either by spontaneous defects [10] or genetic manipulation [11], produces
RDS at birth despite normal amounts of the surfactant lipids. In mice that are genetically
altered to allow control of SP-B expression after birth, the lungs become injured in adult
animals when levels of the protein fall [12]. These results suggest that rapid adsorption of
the surfactant vesicles, facilitated by the hydrophobic surfactant proteins, is required for
normal respiratory function.
The studies reported here concern the possibility that the kinetics of adsorption are
determined by the stability of a tightly-curved structure intermediate between the surfactant
vesicles and the interfacial film. Unlike classical surfactants, which adsorb as individual
molecules, the constituents of pulmonary surfactant insert collectively into the air–water
interface as bilayer vesicles [13–15]. Constituents that promote adsorption, such as the
hydrophobic surfactant proteins and the low-melting surfactant phospholipids, accelerate the
process whether located exclusively in the vesicles or in preexisting films at the interface
[16,17]. For the low-melting phospholipids, the beneficial effects in the two locations are
identical [17]. These results strongly suggest that adsorption proceeds via an intermediate
structure that is equally accessible from both locations. A structure analogous to the stalk-
intermediate proposed for the fusion of two vesicles [18–20] represents one such possibility.
The outer leaflet of the adsorbing vesicle would rupture to form two parts, each of which
would fold back on itself to achieve the correct orientation for insertion of the phospholipids
into the air–water interface [21]. These leaflets would then have the same inverse or
negative curvature, concave on their polar face, that occurs in the hexagonal-II (HII) phase.
Consistent with this possibility, lipids that form the HII phase adsorb rapidly [22,23]. The
hydrophobic proteins might accelerate adsorption by inducing the same negative curvature.
The effects of compounds on the spontaneous curvature of lipid leaflets can be difficult to
detect. Conflicting energetic considerations can frustrate the tendency of the lipids to bend
[24], resulting in a bilayer in which the curvatures of the two opposing leaflets cancel to
yield a planar structure. Consequently the spontaneous curvature of a leaflet, obtained in the
absence of applied force, is inaccessible in systems such as pulmonary surfactant that form
bilayers. Evidence that SP-B and SP-C tend to produce curvature is therefore limited [25].
The model, however, in which the hydrophobic surfactant proteins accelerate adsorption by
stabilizing negatively curved structures, makes other predictions. Any peptide that induces
the HII phase should also facilitate adsorption. Gramicidin A (GrA) is a well-characterized,
readily available membrane peptide that under appropriate conditions induces dioleoyl
phosphatidylcholine (DOPC), but not dimyristoyl phosphatidylcholine (DMPC), to form the
HII phase [26–29]. The studies here first use small angle X-ray scattering (SAXS) and 31P-
nuclear magnetic resonance (NMR) to confirm that at a set of conditions appropriate for
studying adsorption, mixtures of GrA with DOPC, but not with DMPC, form HII structures.
We then determine if under those conditions, GrA can replicate the changes in the
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adsorption of those two lipids that the surfactant proteins produce in the adsorption of the
surfactant lipids.
2. Materials and methods
2.1. Materials
Calf Lung Surfactant Extract (CLSE), prepared as described previously [30], was obtained
from Dr. Edmund Egan (ONY, Inc., Amherst, NY). A preparation containing the complete
set of Neutral and PhosphoLipids (N&PL) without the proteins was isolated from CLSE
using gel permeation column chromatography [21,31]. GrA from Bacillus brevis of ≥90%
purity was purchased commercially and used as received (Product Number 50845, Sigma-
Aldrich Co, St. Louis, MO). DMPC and DOPC were obtained from Avanti Polar Lipids
(Alabaster, AL), each found to produce a single spot on thin layer chromatography, and used
without further purification. The concentration of phospholipid in stock solutions was
determined by assay of total phosphate [32]. Water purified with a multicartridge system
and exposure to dual wavelengths of ultraviolet light (Barnstead International, Dubuque, IA)
contained low levels of organic contaminants (<2 ppb) and electrolyte (resistivity 18.2 MΩ-
cm) and was used throughout the experimental work. All other chemicals and solvents used
in these experiments were analytical grade.
2.2. Methods
2.2.1. Preparation of lipid vesicles—Samples of phospholipid and GrA were prepared
at specific molar ratios by co-dissolving appropriate amounts of lipid and peptide in
trifluoroethanol (TFE) and vortexing in round-bottom test tubes. After complete mixing, the
solvent was evaporated with a stream of nitrogen. The resulting GrA/lipid film was placed in
a vacuum desiccator overnight to remove the last trace of solvent, and then hydrated with 10
mM HEPES pH 7.0, 150 mM NaCl for an hour to a concentration of 30 mM phospholipid
and resuspended by several cycles of sequential heating to 50 °C with vortexing for 3 min
followed by cooling in an ice bath. The crude GrA/lipid vesicles were dispersed further in a
water-bath sonicator for thirty min. The kinetics of adsorption were measured after
overnight incubation of the sonicated vesicles. Samples of N&PL or CLSE for
measurements of surface tension were prepared after drying appropriate amounts of material
in chloroform. The completely dried film was then hydrated with 10 mM HEPES pH 7.0,
150 mM NaCl, 1.5 mM CaCl2 and dispersed by the same methods used for GrA-lipid.
Quasi-elastic light scattering (DynaPro Light-Scattering Instrument, Protein Solutions, Inc.,
Charlottesville, VA) was used to characterize the size of the dispersed particles.
2.2.2. Measurements of surface tension—Surface tension was measured using a force
transducer (KSV Instruments Ltd., Helsinki, Finland) attached to a 0.3-cm-wide Wilhelmy
paper plate. The microelectronic feedback system allowed the surface tension to be recorded
directly to a computer using programs constructed with the graphical user interface
LabVIEW (National Instruments, Austin, TX). The measurements used a Teflon beaker with
a 4.0-cm2 cross-section kept in a fully humidified chamber maintained at 37.0±0.5 °C with a
circulating water bath. A fixed volume of 20 ml buffer was added to the Teflon beaker, and
after temperature equilibration, 100 μl of vesicles at 30 mM phospholipid were injected into
the subphase. After gently stirring for 15 min to provide complete mixing, adsorption to an
initially clean interface was followed by measuring surface tension after removal of the
interfacial film above the dispersed vesicles [21,33].
In experiments concerning the adsorption of lipid vesicles to preformed monolayers, lipid
and peptide/lipid mixtures in solvent were spread at the air–water interface using a
microsyringe (Hamilton, Reno, NV) to produce a final surface concentration of 1.02 μmol/
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m2 phospholipid. Experiments involving GrA used a spreading solvent of CHCl3 for the
phospholipids alone and 13:1 (v/v) CHCl3/TFE for peptide/lipid mixtures. After incubation
for 15–20 min to allow evaporation of spreading solvents, 100 μl of vesicles at 30 mM
phospholipid without GrA were injected through a Teflon tube previously dipped into the
subphase maintained at 37.0±0.5 °C. The subphase was stirred gently without disturbing the
Wilhelmy plate to produce homogeneous mixing. Adsorption of N&PL vesicles to
monolayers of N&PL or CLSE prespread from CHCl3 with a surface concentration of 1.02
μmol/m2 phospholipid was measured following injection of 100 μl N&PL dispersions at 20
mM phospholipid into the gently stirred subphase maintained at 37 °C.
Measurements of surface tension as a function of time are shown as representative curves to
illustrate features that can be lost in averaged traces, with mean±S.D. for at least three
experiments shown at selected points to indicate the variance of the data.
2.2.3. Small-angle X-ray scattering (SAXS)—A home-built X-ray diffractometer was
used to measure SAXS from GrA-lipid mixtures. The instrument is equipped with an X-ray
generator (XRD-3000, Phillips) operating at 45 kVand 20 mAwith a sealed fine-focus
copper tube. The collimated monochromatic X-ray beam (λ =1.54 Å) was produced using a
β-nickel filter and a pinhole collimator. The instrument was calibrated using lead stearate (d
=49.8 Å) as the standard. Measurements were performed on GrA/ lipid vesicles at 30 mM
phospholipid sealed in glass capillaries (1 mm diameter) maintained at 37.0±0.2 °C. The
diffraction patterns were collected using a linear position-sensitive detector (spatial
resolution of 92 μm/channel) interfaced to a personal computer through a multichannel
analyzer (ND-53, Nuclear Data, Canbera Industries, Meriden, CT). Data were collected for
each sample until the integrated intensity reached a common fixed value of 500,000 counts.
The original data obtained as intensity versus channel number were converted to intensity
versus q-spacing using the distances from sample to detector and from channel to the beam
spot, along with the wavelength of the X-rays used for the measurement. To correct for
small differences in intensity caused by the different capillary tubes, each set of data was
normalized with respect to the peak immediately adjacent to the beam-block that results
from scattering in air. Each diffraction peak was fit using a nonlinear least-squares routine to
a Gaussian profile. Best-fit values yielded the peak position, intensity, and associated
variances (3 S.D.).
2.2.4. Nuclear Magnetic Resonance (NMR)—Proton-decoupled 31P-NMR spectra
from non-spinning GrA-lipid dispersed samples at 30 mM phospholipid were collected on a
spectrometer (AMX-400, Bruker, Billerica, MA) using 2H-NMR as an internal lock. Each
spectrum was collected at a probe temperature of 37 °C with 2000 scans at a 2-s repetition
interval using a 15° pulse-width and 100 kHz sweep-width. A linewidth-broadening factor
of 100 Hz was applied prior to Fourier transformation. Zero in the frequency domain
corresponded to the chemical shift of phosphoric acid in D2O. Chemical shift anisotropy
(CSA) and lamellar volume fraction were determined by fitting simulated curves to the
actual spectra using standard equations for an axially symmetric powder patterns and
Lorentzian line-shapes for isotropic peaks [34]. Chemical shift anisotropies, line-widths and
relative volume fractions were varied in a nonlinear least-squares program to obtain the
optimal simulations. Inclusion of at most two kinds of line-shapes was sufficient to fit the
spectra in all cases.
3. Results
3.1. Small angle X-ray scattering
Previous studies have shown that at the peptide/lipid ratios considered here, GrA can induce
DOPC, but not DMPC, to form the HII phase [26–29,35–37]. We first confirmed that the
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same structural effects occurred for the particular conditions of temperature, composition
and concentration that were convenient for studying adsorption. SAXS was measured for
lipid alone and in combination with increasing amounts of GrA. Each phospholipid without
peptide produced prominent first and second order peaks (Fig. 1), indicating the presence of
a regularly repeating structure capable of diffraction. For the dispersed samples used in these
measurements, the observed pattern of X-ray scattering suggested the formation of
multilamellar vesicles. In the absence of GrA, the d-spacing, given by (d =2π/q), of the two
peaks for both DMPC and DOPC occurred in a ratio close to the value of 2 (Table 1)
expected for lamellar structures [38].
GrA produced different changes in the diffraction patterns for the two phospholipids (Fig.
1). For DMPC (Fig. 1A), the initial addition of GrA to 0.02 (mol/mol) GrA/lipid increased
the intensity of the two peaks and their d-spacing, while maintaining the same d1/d2 ratio
(Table 1). Additional GrA had no effect on the d-spacing, but the intensity of the peaks
decreased. At 0.25 GrA/DMPC, the peaks were barely evident above noise. The d1/d2 ratio
for all levels of GrA remained fixed at 2. With DOPC (Fig. 1B), GrA had little effect on the
d-spacing of the first order peak, but the second peak broadened at 0.02 GrA/lipid, and then
appeared in response to additional GrA at a different location. At and above 0.04 GrA/
DOPC, d1/d2 closely approximated the value of √3 (Table 1) expected for the nonlamellar
HII phase [38]. GrA also produced a progressive decrease in the intensity of the diffraction
peaks. SAXS, therefore, demonstrated that GrA decreased diffraction intensity with both
phospholipids, but shifted the d1/d2 ratio from the lamellar to the HII value [38] only with
DOPC.
3.2. 31P-NMR spectra from lipid vesicles
31P-NMR spectroscopy provided a second method for determining microstructure in the
lipid dispersions under the conditions used to study adsorption. Both pure lipids without
GrA exhibited the axially symmetric powder pattern (Fig. 2), with a low-field shoulder and a
high-field peak, that results from a lamellar structure [34]. Analogous to the results with
SAXS, GrA produced different changes with the two lipids. With DMPC, GrA at 0.10 (mol/
mol) peptide/lipid significantly reduced the chemical shift anisotropy (CSA) (Table 2), but
preserved the same line-shape (Fig. 2A). The reduced CSA could reflect two processes. GrA
could reorient the rotational axis of the phosphate group, or it could produce greater disorder
[39,40]. A further increase in GrA to 0.25 peptide/ lipid produced a complex line-shape that
suggested an isotropic peak, centered at 0 ppm, combined with the standard axially
symmetric powder pattern of a lamellar phase. As with SAXS, 31P-NMR showed no
evidence of the HII phase.
The addition of GrA to DOPC at a molar ratio of 0.10 changed the line-shape (Fig. 2B).
Relative to DOPC alone, the symmetry of the spectrum was reversed, exhibiting the low-
field peak and high-field shoulder that is characteristic of the HII phase [34]. The altered
line-shape, along with the SAXS results, confirmed that the hexagonal structure observed
previously by other workers [27,35–37] was present under the conditions of our
experiments. The width of the peak also decreased with GrA (Fig. 2B, Table 2) by 2.6, more
than the factor of two expected for the simple shift from a lamellar to hexagonal phase [34].
Like the changes with DMPC at 0.10 GrA/lipid, the CSA could again reflect either
reorientation of the phosphate group or greater disorder [39,40]. GrA therefore had
additional structural effects beyond inducing DOPC to adopt the spontaneously curved
hexagonal structures.
We also considered the possibility that the effect of GrA on CSA might reflect a decrease in
vesicular size. Although the mechanism of the effect is debated [40], smaller particles of the
same lipids have a reduced CSA. We used quasi-elastic light scattering to measure the
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average hydrodynamic diameter for particles in the different GrA-lipid preparations. For
samples containing GrA/DMPC ratios (mol/mol) of 0, 0.1 and 0.2, the diameter increased
from 124 to 188 to 220 nm, respectively. With DOPC, the diameter decreased minimally
from 246 nm for the pure lipid to 220 nm for 0.067 (mol/mol) GrA/DOPC, above which
turbidity prevented accurate measurements. For all samples, the diameter remained well
above the maximum value of 50 nm at which size should affect line-narrowing [39]. The
decreased CSA with GrA, therefore, seemed unlikely to result from a change in size of the
vesicles.
3.3. Adsorption: effect of hydrophobic proteins/peptides in vesicles
Our studies required that we determine if GrA can produce the same effects on the
adsorption of phospholipids that the hydrophobic surfactant proteins have on the surfactant
lipids. To document the role of the surfactant proteins, we compared the decrease in surface
tension produced by the complete set of constituents extracted from calf surfactant (Calf
Lung Surfactant Extract, CLSE) with adsorption of the Neutral and PhosphoLipids (N&PL),
from which the proteins had been removed (Fig. 3). Gel permeation chromatography
reduces the level of protein in N&PL to undetectable levels while maintaining the same set
of phospholipid headgroups and acyl chains [31,41]. Dispersions made from N&PL
adsorbed more slowly than CLSE. For N&PL, surface tension fell at continuously
decreasing rates to 50 mN/m in 200 min. For CLSE dispersions, surface tension fell at rates
that slowed until reaching 40–45 mN/m, but adsorption then accelerated until surface
tension reached a final value of ~25 mN/m in 9 min. This late acceleration for CLSE
produced an inflection point in the adsorption isotherm, which has been reported previously
[21,42]. The hydrophobic surfactant proteins, therefore, produced not only a general
acceleration of adsorption, but also a distinct late stage.
To determine if the effects of GrA on adsorption of DMPC and DOPC were comparable to
those of the hydrophobic surfactant proteins on the surfactant lipids, we measured
adsorption of phospholipid dispersions with a range of GrA/ lipid molar ratios (Fig. 4). The
pure lipid dispersions, without GrA, adsorbed slowly. Incorporation of GrA in both cases
produced a dose-dependent increase in the initial rate at which surface tension fell. The
peptide with both DMPC and DOPC also generated the same late acceleration observed with
CLSE (Fig. 4). At all GrA/lipid ratios, including for the pure lipids, the vesicles with DMPC
(Fig. 4A) adsorbed more slowly than with DOPC (Fig. 4B). The qualitative effects of GrA
with both phospholipids, however, were similar to each other and to the effects of the
surfactant proteins on the surfactant lipids.
3.4. Adsorption: effects of proteins/peptides at the interface
Prior studies have shown that in addition to accelerating adsorption when present in vesicles
of DPPC/DPPG, SP-B also promotes adsorption when confined to the air–water interface
[16,43]. In experiments here with the complete set of surfactant lipids, the presence of the
surfactant proteins exclusively in a preformed layer showed similar effects. N&PL vesicles
adsorbed faster to a preexisting monolayer containing CLSE than to a film of N&PL without
the proteins (Fig. 5).
To determine if GrA also promoted adsorption when restricted to the interface, we measured
the adsorption of phospholipid vesicles, without GrA, to preformed monolayers containing a
fixed surface concentration of the same lipid with different amounts of GrA (Fig. 6). For
DMPC, the presence of GrA in the preformed film had no effect (Fig. 6A). With levels as
high as 255 nmol/m2, corresponding to a peptide/lipid ratio of 0.25, GrA produced no
change in adsorption. GrA at the interface, however, did affect adsorption of vesicles
containing only DOPC (Fig. 6B). With monolayers having the same phospholipid surface
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concentration but also containing 102 nmol/m2 or 255 nmol/m2 GrA (GrA/DOPC ratios of
0.10 and 0.25, respectively), surface tension fell to the same final value obtained by GrA-
DOPC vesicles within 40 and 10 min, respectively. Adsorption to the films with GrA also
showed the late acceleration. When confined to the interface, GrA therefore replicated the
qualitative effects of the surfactant proteins, but only with the lipid in which it formed the
HII phase, and not with DMPC that remained lamellar.
4. Discussion
Prior studies suggest that the hydrophobic surfactant proteins facilitate adsorption of the
surfactant lipids by stabilizing a negatively curved structure that bridges the gap between the
vesicles and the interface [21]. The outer lipid leaflet would fold back on itself to insert the
lipids into the interface with the correct orientation. One hypothesis generated by the model
is that other factors which stabilize negative curvature should produce the same functional
consequence of faster adsorption. The current studies use induction of the HII phase, not to
demonstrate the presence of an essential equilibrium structure, but as an indication that with
DOPC, GrA can stabilize the negative curvature that would be present in the proposed
transient intermediate. Under conditions at which GrA induces DOPC to form the HII phase,
the peptide produces the same changes in adsorption that the hydrophobic proteins generate
with the surfactant lipids. The correspondence of the structural and functional effects
produced by GrA with DOPC therefore supports the model in which hydrophobic peptides
such as the surfactant proteins stabilize the negatively curved intermediate.
The effects of the surfactant proteins at the interface provide crucial evidence for the model.
In preexisting films, the surfactant proteins promote adsorption of vesicles that contain only
lipids. Our results show that this observation, originally made with model lipids [16],
extends to the complete set of surfactant lipids. The similar effects on adsorption of the
proteins at the interface and in the vesicles strongly suggest that they affect a structure
equally accessible from the two locations. The findings here, that a peptide can have the
same effect under conditions at which it induces formation of the HII phase, supports the
importance of negative curvature in that bridging structure.
Both SAXS and 31P-NMR indicate that with DOPC, GrA induces the HII phase under the
particular conditions of our adsorption experiments, and that the peptide therefore stabilizes
a negatively curved structure. The mechanism by which the peptide produces that
stabilization remains unspecified. One possibility is that GrA reduces the energy of bending.
If a lipid leaflet can be considered as a continuum layer, then for weakly bent leaflets, the
bending elastic energy per unit area, g, is given by:
where co is the spontaneous curvature in the absence of applied force, c1 and c2 are the
curvatures along the principal radii of the actual structure, and κ and κ̄ are the curvature-
elastic moduli of splay and saddle-splay, respectively [44–46]. Factors such as peptides
could lower the bending energy by inducing a spontaneous curvature, by decreasing the
elastic moduli, or by producing both effects.
Recent studies suggest that GrA affects co [47]. Determination of co requires evaluation of
lipid structures containing individual unpaired leaflets, so that the tendency to bend is not
frustrated in a bilayer by the opposing curvature of the other leaflet. GrA produces a dose-
related decrease in the d-spacing of the HII phase formed with DOPC, indicating that the
peptide generates tighter curvature and a change in co [47].
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Our NMR results suggest that in addition to affecting curvature of the DOPC leaflets, GrA
also affects their flexibility by reducing κ. The CSA of 31P-NMR depends on orientational
averaging of the phospholipid headgroup, and is proportional to the orientational order
parameter S [34,48]. Without other changes, reconfiguration of lipids from a planar to a
cylindrical assembly reduces the CSA by a factor of two [34,49]. For our system, the change
induced by GrA is somewhat larger. GrA therefore must produce an additional structural
effect beyond the shift to the new phase. The greater-than-expected CSA could reflect a
common reorientation of the phosphate groups within the leaflet, or an additional motional
averaging of the phosphate head group. Although our experiments provide no definitive
distinction between these two explanations, greater disorder would imply a more flexible
leaflet. The orientational order parameter S is related to the bending modulus by κ α S2
[50,51], and therefore an increase in disorder would change κ. The ability of GrA to
stabilize a negatively curved DOPC structure might therefore result to some extent from
greater flexibility as well as a change in spontaneous curvature.
Our results with DMPC should be interpreted with caution. At the conditions used here, GrA
with DMPC induces greater disorder and a general acceleration of adsorption, but not
formation of the HII phase or any effect on adsorption from the interface. The similarities
and differences between the two lipids therefore suggest that greater disorder in the lipid
vesicles is sufficient to promote their adsorption, but that effects from the interface require
structures with spontaneous curvature. The extent, however, to which GrA changes
spontaneous curvature with DMPC remains unknown. DMPC with the peptide continues to
form bilayers in which any curvature in the two individual leaflets would be cancelled by
their opposite orientation. Although the results with DMPC generally agree with the model,
they provide evidence that is less conclusive than suggested by superficial review.
Our results generally support adsorption via a negatively curved structure, but they do not
exclude all other possibilities. A recently proposed model of fusion, for instance, suggests
that two bilayers, brought into sufficiently close proximity by fusogenic proteins, might lack
the intervening aqueous environment necessary to maintain the orientation of lipid
constituents in the opposing leaflets [52]. The lipids might then simply flip. For a vesicle
approaching an air–water interface, such a reorientation of constituents in the outer leaflet
would produce the alignment required for a stable surface film. Although at least the initial
vesicles would seem to lack a process that would drive approach to the interface close
enough to cause the necessary dehydration, our results provide no evidence that contradicts
this or other models. Our findings, however, do directly support models in which negative
curvature is an important component of rate-limiting kinetic intermediates.
In summary, our results show that under conditions at which GrA stabilizes negatively
curved structures with DOPC, the peptide also causes the same functional effects on the
adsorption of DOPC that the hydrophobic surfactant proteins produce with the surfactant
lipids. Our results support a model in which the hydrophobic proteins promote adsorption by
stabilizing a rate-limiting structure with negative curvature that is intermediate between the
vesicular bilayer and the interfacial film.
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Fig. 1.
SAXS from dispersed samples of phospholipid with different amounts of GrA. Profiles were
obtained with a constant phospholipid concentration of 30 mM in buffered saline (150 mM
NaCl, 10 mM HEPES pH 7.0) at 37 °C. The first and second order diffraction peaks are
labeled for phospholipid without GrA. For clarity of presentation, the curves for the different
experiments are each shifted by a constant value of intensity. (A) DMPC. (B) DOPC.
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Fig. 2.
31P-NMR spectra of phospholipid with and without GrA. Spectra were obtained with a
constant phospholipid concentration of 30 mM in buffered saline (150 mM NaCl, 10 mM
HEPES pH 7.0) at 37 °C. (A) DMPC. (B) DOPC.
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Fig. 3.
Adsorption of the pulmonary surfactant lipids in the presence (CLSE) and absence (N&PL)
of the hydrophobic surfactant proteins. Curves show the variation of surface tension after
removing the surface film from a dispersion of vesicles at 100 μM phospholipid and 37 °C
in buffered saline with calcium (150 mM NaCl, 1.5 mM CaCl2, 10 mM HEPES pH 7.0).
Curves are representative of three experiments. Symbols give mean±S.D. at specific times to
indicate the variance among different experiments.
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Fig. 4.
Adsorption to the air–water interface of phospholipid vesicles with different amounts of
GrA. Experiments were performed at 150 μM phospholipid in buffered saline (150 mM
NaCl, 10 mM HEPES pH 7.0) at 37 °C. Ratios of GrA/DOPC are mole/mole. Curves are
representative of at least three experiments, with mean±S.D. shown at selected times. (A)
DMPC. Data for GrA/DMPC of 0.02 and 0.07, which are omitted for clarity of presentation,
fit in the sequence of curves according to the dose of GrA. (B) DOPC. Omitted data for
GrA/DOPC of 0.02, 0.04, 0.10 similarly fit in the sequence of curves according to the dose
of GrA.
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Fig. 5.
Adsorption of N&PL vesicles to prespread films with and without the hydrophobic
surfactant proteins. Experiments were performed at 37 °C by injecting 100 μl vesicles of
N&PL into a well-stirred subphase (150 mM NaCl, 1.5 mM CaCl2, 10 mM HEPES pH 7.0)
to a final concentration of 100 μM phospholipid below a preexisting film containing either
N&PL or CLSE at 1.02 μmol/m2 phospholipid. Curves are representative of at least three
experiments. Symbols indicate the mean±S.D. at selected times.
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Fig. 6.
Adsorption of phospholipid vesicles to preformed phospholipid films containing different
amounts of GrA. Experiments were performed at 37 °C by injecting 150 μl of lipid vesicles
without GrA to a final concentration of 150 μM lipid into a well stirred subphase (150 mM
NaCl, 10 mM HEPES pH 7.0) below a prespread film containing 1.02 μmol/m2
phospholipid with different amounts of GrA. Curves are representative of at least three
experiments. Symbols give the mean±S.D. at selected times. (A) DMPC. (B) DOPC.
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Table 2
NMR analysis of DOPC mixed with GRA
GrA/lipid (mol/mol)
Chemical shift anisotropy (ppm)
Lamellar volume fraction
Lamellar Isotropic
DMPC
0.00 −46.4±0.2 – –
0.10 −33.5±0.2 – –
0.25 −27.5±0.1 −0.05±0.03 0.78±0.03
GrA/lipid (mol/mol)
Chemical shift anisotropy (ppm)
Lamellar volume fraction
Lamellar Hexagonal
DOPC
0.00 −46.7±0.2 – 1.00
0.10 −41.3±0.2 18.3±0.1 0.21±0.01
Data are best-fit values±3 S.D. with respect to the fitting function.
